Adding a new drug to current weight-loss therapy for adults with obesity or overweight
Part of Hormones & metabolism clinical trials.
This study tests a new medication (AZD6234) added to your current weight-management medication (an incretin-based drug) to see if it helps with weight loss. You may be eligible if you are overweight or obese with related health issues or type 2 diabetes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a body mass index (BMI) of 30 or higher, or a BMI of 27 or higher with a weight-related health condition (like high blood pressure, sleep apnea, heart disease, or knee osteoarthritis).
- If you have type 2 diabetes, it must be controlled (between 6% and 9% on a standard test), and you can't be on insulin.
- You have been on a stable dose of an incretin-based medication (such as a GLP-1 drug) for at least 3 months.
- Your weight hasn't changed by more than 3% in the last 3 months.
- You've tried to lose weight before but didn't succeed long-term.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medicine called petrelintide to help people with excess weight and type 2 diabetes lose weight and improve blood sugar control. It may be an option if you've struggled with weight loss through diet alone.
This study tests a new medicine to help adults with obesity or overweight lose weight. It's for people who have had trouble losing weight in the past and don't have diabetes.
This study tests a new injected medicine that may help people with type 2 diabetes and overweight or obesity lose weight. The trial will see how well it works and if it is safe compared to a placebo.
This study tests a new combination of two medicines, petrelintide and enicepatide, given as a shot to help with weight loss in people who are overweight or have obesity. The goal is to find the best dose and see if it works well and is safe.
This study tests a new medication called petrelintide to see how well it helps people lose weight and improve their health. It's for adults with overweight or obesity who have struggled to lose weight with diet alone.
This study tests how well adults with overweight or obesity, with or without type 2 diabetes, tolerate switching from their current weight-loss medication (tirzepatide) to a new medicine called zenagamtide. It may help you understand if this new option is easier on your stomach.
Hear when a new Obesity or Overweight trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.